//
MEDTRADE works with inventors, scientific teams, biotechnology companies and technology owners to evaluate patented healthcare technologies and explore practical pathways toward licensing, localization, production and market implementation. We connect intellectual property with technical assessment, regulatory preparation, investment structuring and pharmaceutical market access.
A patent can protect a scientific idea, process, formulation, device or production technology, but intellectual property alone does not create a commercially viable healthcare project.
Successful implementation may require technical validation, regulatory assessment, manufacturing adaptation, investment, licensing agreements and access to the appropriate market channels.
MEDTRADE supports the preliminary evaluation and coordination of biotechnology and pharmaceutical intellectual property with potential relevance to Uzbekistan and selected regional markets.
Patented or proprietary processes involving cells, microorganisms, proteins or biological materials.
New formulations, delivery systems, combinations or dosage technologies.
Technologies related to recombinant products, biosimilars and other biological therapies.
Platforms involving cell processing, preservation, expansion or therapeutic applications.
Biological, laboratory or point-of-care diagnostic systems.
Production, purification, formulation, filling or quality-control technologies.
Specialized healthcare devices, materials or technical systems.
Technologies supporting temperature-controlled storage, transport and biological material handling.
Each technology is evaluated individually based on its scientific, legal, regulatory and commercial characteristics.
The invention or technical principle has been defined.
Initial laboratory or technical evidence supports the proposed mechanism.
A working prototype, formulation or laboratory process has been developed.
The technology has been tested at pilot or expanded laboratory scale.
Technical documentation, process parameters and manufacturing requirements are sufficiently developed for transfer assessment.
The technology is integrated with production, regulatory approval and market access.
Not all submitted technologies will be suitable for immediate licensing or commercialization. Some may require additional scientific or technical development.
The technology owner grants defined rights to use the patent, process or know-how under agreed conditions.
A partner may receive defined rights for Uzbekistan, Central Asia or another agreed territory.
Production documentation, methods, know-how and training are transferred to a local implementation partner.
The technology owner and project partners jointly complete development and prepare the technology for production or registration.
The technology and project resources may be combined within a dedicated operating structure.
In selected cases, full or partial acquisition of intellectual property rights may be considered.
The appropriate structure depends on ownership, patent status, technology maturity, investment requirements and commercial objectives.
Patent documentation may describe the protected invention, but successful implementation often depends on additional confidential knowledge and practical experience.
A technology-transfer package may include:
Patent and technology discussions may involve confidential scientific, technical and commercial information.
MEDTRADE supports a structured review process designed to limit unnecessary disclosure during the initial evaluation stage.
The first submission should contain enough information to understand the technology without disclosing essential confidential know-how.
Where appropriate, more detailed materials may be reviewed after execution of a confidentiality agreement.
Sensitive files should be shared only with relevant participants involved in the evaluation.
Information is reviewed only for the agreed purpose of evaluating potential cooperation.
Submission or review does not grant MEDTRADE ownership, licence rights or permission to use the technology.
Do not submit confidential information through an open website form unless a confidentiality agreement or secure review process has been established.
MEDTRADE may support coordination across the following areas:
Preliminary review of technical maturity, documentation and implementation requirements.
Coordination of discussions between patent owners, manufacturers, investors and scientific teams.
Support in defining the intended territory, rights, responsibilities and commercial model.
Preliminary identification of product classification and development requirements.
Assessment of localization, pilot production, scale-up or technology-transfer options.
Coordination of project requirements, implementation stages and potential financing discussions.
Connection with distribution, healthcare channels, commercial positioning and regional development.
MEDTRADE does not replace qualified patent attorneys, intellectual property counsel or official patent authorities.
Individuals holding patents or proprietary healthcare technologies.
Researchers developing biotechnology, pharmaceutical or diagnostic solutions.
Organizations seeking commercialization or industrial partnerships.
Companies with patented platforms, processes or healthcare products.
Manufacturers seeking technologies for licensing or localization.
Companies or institutions holding intellectual property rights.
Partners interested in financing technology development and commercialization.
Organizations capable of implementing technologies at pilot or industrial scale.
The initial documentation package may include:
Confidential know-how, unpublished protocols or sensitive data should only be provided through an agreed confidential review process.
Submission and review do not constitute acceptance, licensing commitment, investment approval or confirmation of commercial viability.
Formal patent validity, freedom-to-operate and infringement assessments should be performed by qualified intellectual property professionals in the relevant jurisdictions.
Technology ownership remains with the lawful rights holder unless otherwise agreed in writing.
Only information necessary for the relevant stage of evaluation should be disclosed.
Any licence, exclusivity, acquisition or technology-transfer rights must be defined in formal agreements.
Patent status, ownership and legal validity may require independent professional verification.
Patent protection does not by itself confirm technical feasibility or market demand.
Review of a technology does not create an obligation to invest, license, acquire or commercialize it.
Submit a non-confidential summary of your patent, scientific platform or proprietary technology. Our team will review the initial information and determine whether a more detailed technical or commercial discussion may be appropriate.
Do not include confidential know-how in the initial submission. Submission does not create ownership rights, confidentiality obligations or a commitment to cooperation unless separately agreed in writing.
I confirm that the submitted information is non-confidential, that I am authorized to provide it and that submission does not create any licence, ownership transfer or obligation to cooperate.